BSE Live
Oct 30, 16:01Prev. Close
465.75
Open Price
470.00
Bid Price (Qty.)
460.45 (4)
Offer Price (Qty.)
466.25 (9)
NSE Live
Oct 30, 15:53Prev. Close
467.00
Open Price
471.00
Bid Price (Qty.)
466.90 (2082)
Offer Price (Qty.)
0.00 (0)
| Key Financial Ratios of Akums Drugs Pharmaceuticals (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
| Per Share Ratios | |||||
| Basic EPS (Rs.) | 22.60 | -0.28 | 6.63 | -17.65 | |
| Diluted EPS (Rs.) | 22.60 | -0.28 | 6.63 | -17.65 | |
| Cash EPS (Rs.) | 32.48 | 8.84 | 14.74 | -21.86 | |
| Book Value [ExclRevalReserve]/Share (Rs.) | 199.01 | 50.36 | 50.56 | 87.39 | |
| Book Value [InclRevalReserve]/Share (Rs.) | 199.01 | 50.36 | 50.56 | 87.39 | |
| Revenue from Operations/Share (Rs.) | 268.98 | 292.05 | 255.47 | 513.30 | |
| PBDIT/Share (Rs.) | 33.74 | 10.97 | 26.84 | -9.66 | |
| PBIT/Share (Rs.) | 23.72 | 2.19 | 18.96 | -22.89 | |
| PBT/Share (Rs.) | 22.55 | -3.16 | 10.52 | -27.04 | |
| Net Profit/Share (Rs.) | 22.45 | 0.06 | 6.85 | -35.10 | |
| NP After MI And SOA / Share (Rs.) | 22.09 | -0.28 | 6.63 | -35.30 | |
| Profitability Ratios | |||||
| PBDIT Margin (%) | 12.54 | 3.75 | 10.50 | -1.88 | |
| PBIT Margin (%) | 8.81 | 0.75 | 7.42 | -4.46 | |
| PBT Margin (%) | 8.38 | -1.08 | 4.11 | -5.26 | |
| Net Profit Margin (%) | 8.34 | 0.01 | 2.68 | -6.83 | |
| NP After MI And SOA Margin (%) | 8.21 | -0.09 | 2.59 | -6.87 | |
| Return on Networth/Equity (%) | 11.09 | -0.56 | 13.22 | -40.60 | |
| Return on Capital Employed (%) | 11.27 | 1.36 | 13.55 | -9.11 | |
| Return on Assets (%) | 8.22 | -0.11 | 2.90 | -8.22 | |
| Total Debt/Equity (X) | 0.00 | 0.69 | 0.75 | 0.58 | |
| Asset Turnover Ratio (%) | 1.08 | 1.23 | 1.15 | 0.00 | |
| Liquidity Ratios | |||||
| Current Ratio (X) | 2.55 | 1.60 | 1.52 | 1.49 | |
| Quick Ratio (X) | 1.78 | 1.08 | 0.94 | 0.92 | |
| Inventory Turnover Ratio (X) | 3.44 | 3.35 | 2.79 | 0.00 | |
| Dividend Payout Ratio (NP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividend Payout Ratio (CP) (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Cash Earnings Retention Ratio (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Coverage Ratios | |||||
| Interest Coverage Ratios (%) | 14.93 | 3.10 | 8.30 | -4.15 | |
| Interest Coverage Ratios (Post Tax) (%) | 14.93 | 3.10 | 8.30 | -4.15 | |
| Valuation Ratios | |||||
| Enterprise Value (Cr.) | 6,720.16 | 0.00 | 0.00 | 0.00 | |
| EV/Net Operating Revenue (X) | 1.63 | 0.00 | 0.00 | 0.00 | |
| EV/EBITDA (X) | 13.01 | 0.00 | 0.00 | 0.00 | |
| MarketCap/Net Operating Revenue (X) | 1.76 | 0.00 | 0.00 | 0.00 | |
| Retention Ratios (%) | 0.00 | 0.00 | 0.00 | 0.00 | |
| Price/BV (X) | 2.38 | 0.00 | 0.00 | 0.00 | |
| Price/Net Operating Revenue | 1.76 | 0.00 | 0.00 | 0.00 | |
| Earnings Yield | 0.05 | 0.00 | 0.00 | 0.00 | 
22.08.2025
Akums Drugs P Standalone June 2025 Net Sales at Rs 332.44 crore, up 4.78% Y-o-Y
27.05.2025
Akums Drugs P Consolidated March 2025 Net Sales at Rs 1,055.55 crore, up 11.79% Y-o-Y
27.05.2025
Akums Drugs P Standalone March 2025 Net Sales at Rs 328.75 crore, up 10.19% Y-o-Y
12.02.2025
Akums Drugs & P Standalone December 2024 Net Sales at Rs 337.41 crore, down 11.94% Y-o-Y
22.08.2025
Akums Drugs P Standalone June 2025 Net Sales at Rs 332.44 crore, up 4.78% Y-o-Y
27.05.2025
Akums Drugs P Consolidated March 2025 Net Sales at Rs 1,055.55 crore, up 11.79% Y-o-Y
27.05.2025
Akums Drugs P Standalone March 2025 Net Sales at Rs 328.75 crore, up 10.19% Y-o-Y
12.02.2025
Akums Drugs & P Standalone December 2024 Net Sales at Rs 337.41 crore, down 11.94% Y-o-Y